KDM6B and neoplasm: Seven days after cancer cell inoculation the tumor-bearing nude mice were split into 5 groups (n = 5 per group) and were intraperitoneally injected with GSK-J4, a dual inhibitor of H3K27me3/me2-demethylases JMJD3, or OXA.